RankingsPricing
  1. US-listed companies
  2. AMGEN INC
  3. Financials
  4. Cash and cash equivalents

AMGEN INCAMGN

Market cap
$174.4B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 202411,973+9.40%
Dec 31, 202310,944+43.45%
Dec 31, 20227,629-4.51%
Dec 31, 20217,989+27.50%
Dec 31, 20206,266+3.79%
Dec 31, 20196,037-13.07%
Dec 31, 20186,945+82.76%
Dec 31, 20173,800+17.25%
Dec 31, 20163,241-21.79%
Dec 31, 20154,144+11.07%
Dec 31, 20143,731-1.94%
Dec 31, 20133,805+16.83%
Dec 31, 20123,257-53.11%
Dec 31, 20116,946+111.32%
Dec 31, 20103,287

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)